Loading
Latest filing published 27 Jan 2016 for LISATA THERAPEUTICS, INC.. Read the official filing
No signal scores available.
Douglas W. Losordo discloses dealings in Lisata Therapeutics, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 5 August 2015 to 25 January 2016.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 27 January 2016: a share grant, in Lisata Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations